CTOR ▲ +8.6% - Citius Oncology, Inc. $CTOR CTOR CTXR - Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026 26-OCT-2026 01:00 PM ET